ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.191,91
0,46%
S&P 500
5.220,58
-0,04%
US Dollar vs BRL
5,1521
0,11%
Bitcoin
63.080,15
2,66%
Brent Oil
83,26
1,06%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Allena Pharmaceuticals Inc (ALNA)

  7. Allena Pharmaceuticals Inc (ALNA) Notícias

ALNA

Allena Pharmaceuticals (ALNA)

Allena Pharmaceuticals Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ALNA
DataHoraFonteTítuloCódigoCompanhia
14/11/202218:04Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:ALNAAllena Pharmaceuticals Inc
14/09/202210:53Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:ALNAAllena Pharmaceuticals Inc
07/09/202217:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ALNAAllena Pharmaceuticals Inc
13/07/202217:12Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ALNAAllena Pharmaceuticals Inc
12/07/202217:05GlobeNewswire Inc.Allena Pharmaceuticals Announces New Meeting Date and New Record Date for Special Meeting to Approve Reverse Stock SplitNASDAQ:ALNAAllena Pharmaceuticals Inc
11/07/202209:53Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ALNAAllena Pharmaceuticals Inc
05/07/202208:00GlobeNewswire Inc.Allena Pharmaceuticals Announces Rescheduling of Special Meeting to Approve Reverse Stock SplitNASDAQ:ALNAAllena Pharmaceuticals Inc
23/06/202217:46Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:ALNAAllena Pharmaceuticals Inc
24/05/202209:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ALNAAllena Pharmaceuticals Inc
17/05/202216:44Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ALNAAllena Pharmaceuticals Inc
17/05/202210:55TipRanksAllena Pharmaceuticals (ALNA) Receives a Hold from H.C. WainwrightNASDAQ:ALNAAllena Pharmaceuticals Inc
16/05/202217:26Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ALNAAllena Pharmaceuticals Inc
13/05/202217:10Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ALNAAllena Pharmaceuticals Inc
02/02/202218:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALNAAllena Pharmaceuticals Inc
25/01/202218:06Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ALNAAllena Pharmaceuticals Inc
05/01/202213:35TipRanksAllena Pharmaceuticals (ALNA) Receives a Buy from B.Riley FinancialNASDAQ:ALNAAllena Pharmaceuticals Inc
05/01/202208:25TipRanksAnalysts’ Top Healthcare Picks: Allena Pharmaceuticals (ALNA), Unity Biotechnology (UBX)NASDAQ:ALNAAllena Pharmaceuticals Inc
12/11/202118:14Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:ALNAAllena Pharmaceuticals Inc
12/11/202118:08Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ALNAAllena Pharmaceuticals Inc
03/11/202109:45Dow Jones NewsAllena Pharmaceuticals Gets Fast Track Designation for Kidney Disease TreatmentNASDAQ:ALNAAllena Pharmaceuticals Inc
13/08/202108:33TipRanksAllena Pharmaceuticals: a Penny Stock with PotentialNASDAQ:ALNAAllena Pharmaceuticals Inc
08/06/202109:30GlobeNewswire Inc.Allena Pharmaceuticals to Host Key Opinion Leader Webinar Focused on ALLN-346 for the Treatment of Gout in Patients with Chro...NASDAQ:ALNAAllena Pharmaceuticals Inc
11/05/202109:00GlobeNewswire Inc.Allena Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business UpdateNASDAQ:ALNAAllena Pharmaceuticals Inc
06/05/202117:57Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ALNAAllena Pharmaceuticals Inc
04/05/202117:01GlobeNewswire Inc.Allena Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:ALNAAllena Pharmaceuticals Inc
08/04/202115:14Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ALNAAllena Pharmaceuticals Inc
07/04/202109:00GlobeNewswire Inc.Allena Pharmaceuticals Appoints Mark J. Fitzpatrick to its Board of DirectorsNASDAQ:ALNAAllena Pharmaceuticals Inc
11/03/202109:39Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ALNAAllena Pharmaceuticals Inc
11/03/202109:17Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ALNAAllena Pharmaceuticals Inc
09/03/202109:00GlobeNewswire Inc.Allena Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business UpdateNASDAQ:ALNAAllena Pharmaceuticals Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:ALNA

Seu Histórico Recente

BIT
AGP
Altea Green Power
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados